Clinical Trials
65 trialsObserving People With Desmoid-Type Fibromatosis
Memorial Sloan Kettering Cancer Center
Embodesmo
Istituto Ortopedico Rizzoli
ECT-DESMO
Istituto Ortopedico Rizzoli
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
National Cancer Institute (NCI)
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Parabilis Medicines, Inc.
Cryomics
Istituto Ortopedico Rizzoli
Individual Patient Compassionate Use of Nirogacestat
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Project: Every Child for Younger Patients With Cancer
Children's Oncology Group
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Children's Oncology Group
A Study in Adults With Desmoid Tumors
Elpiscience Biopharma, Ltd.
PRISM
Dana-Farber Cancer Institute
A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery
Children's Oncology Group
ALTITUDES
Centre Oscar Lambret
Immunological Phenotype of Desmoid-fibromatosis-affected Patients.
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
PALANGI3
Centre Oscar Lambret
RIPAF
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)
Eisai Inc.
RINGSIDE
Immunome, Inc.
SarcAblate
Oxford University Hospitals NHS Trust
CRYODESMO01
University Hospital, Strasbourg, France
Endoxifen in Adults With Hormone Receptor Positive Solid Tumors
National Institutes of Health Clinical Center (CC)
CRYODESMO-02
University Hospital, Strasbourg, France
TAE-DESMO
Istituto Ortopedico Rizzoli
Tailored Beta-catenin Mutational Approach in Extra-abdominal Sporadic Desmoids Tumor Patients
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Study of Cryoablation and Nirogacestat for Desmoid Tumor
Stanford University
PROSa Desmoid
Technische Universität Dresden
Cryotherapy in the Treatment of Desmoid Tumors
Istituto Ortopedico Rizzoli
RCT of Two Noncrosslinked Porcine Acellular Dermal Matrices in Ab Wall Reconstruction
Ohio State University
Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers
Sarcoma Oncology Research Center, LLC
DeFi
SpringWorks Therapeutics, Inc.
MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors
Children's National Research Institute
A Study to Evaluate the Safety and Efficacy of Vactosertib and Imatinib in Patients With Advanced Desmoid Tumor
Yonsei University
RFAdesmoid
Blokhin's Russian Cancer Research Center
Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis
National Institutes of Health Clinical Center (CC)
CT-guided Radioactive Iodine-125 Seed Implantation for Recurrent Desmoid Tumors
Peking University Third Hospital
CARDT
University Hospital, Strasbourg, France
Clinical Study of Anlotinib Combined With Chemotherapy in the Treatment of Unresectable Advanced Desmoid Tumor
Henan Cancer Hospital
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
Children's Oncology Group
QUALIFIED
Erasmus Medical Center
A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis
MaineHealth
Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis
National Cancer Institute (NCI)
Phase I, Open-label, Non-randomized Study to Evaluate Safety of BC2059
Iterion Therapeutics
Desmoid Tumor and Pregnancy: Effect of Pregnancy on Disease Control and Effect of Diagnosis on Pregnancy History.
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
A Randomized, Double-blind,Phase â…¢ Study of Liposome Doxorubicin in Desmoid Tumor
Sun Yat-sen University
ABRADES
Grupo Espanol de Investigacion en Sarcomas
Doxorubicin Eluting Intra-arterial Embolization for Aggressive Desmoid Fibromatosis
Rabin Medical Center
Optional Sub-study to Intraoperative Imaging With ICG Registry
Abramson Cancer Center at Penn Medicine
Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor
Children's Oncology Group